Tag:
amyloidosis
Latest Headlines
Latest Headlines
Alnylam, Tekmira separately tout amyloidosis RNAi treatment news
Alnylam Pharmaceuticals ( $ALNY ) says it generated promising Phase I trial results for an RNAi compound designed to treat a form of amyloidosis using lipid nanoparticle drug-delivery technology...
A possible solution found for TTR-related amyloid diseases
Conditions such as familial amyloid cardiomyopathy, which causes heart failure, and the neurodegenerative disease senile systemic amyloidosis are the result of a protein called transthyretin (TTR),
GSK inks amyloidosis research pact with professor
GlaxoSmithKline has struck an innovative research deal with a noted professor at University College London aimed at developing an antibody that can be combined with an existing drug to fight
